Additional criteria are recommended to improve the inter-tester agreement for symptomatic subjects.
However, evidence is limited on whether symptomatic subjects can actively maintain the scapula in a neutral position through conscious control.
Design: Cohort study comparing perception of verticality in symptomatic subjects with neck pain versus a control group.
The symptomatic subjects were older (P<.05), heavier (P<.05), and shorter (P<.05) than the pain-free group.
The aim of this study is to compare standard practice guided by usual care testing to FFRCT-guided management in symptomatic subjects with suspected coronary artery disease (CAD).
Symptomatic subjects did not differ from nonsymptomatic subjects with respect to differences between left and right calf diameter or the frequency of palpable nodules.
The improving rates of upper gastrointestinal symptomatic subjects and total symptom numbers in the BF-1 group were higher than those in the placebo.
In addition, in high symptomatic subjects (as indexed by greater increases in heart rate post-administration), nicotine (vs. placebo) produced greater P1 amplitudes in valid cue trials.
In symptomatic subjects (n = 9), gene-expression data on the day of peak symptoms was analysed.
Other limitations of our study design include the potential bias from recruiting symptomatic subjects, resulting in three distinct effects.
Data from twelve presymptomatic gene mutation carriers (pHD) (N = 12), ten symptomatic subjects (HD) (N = 10) and twelve healthy controls (N = 12) was analyzed.
